A thorough clinical assessment, including medical history, current medications, and discussion of treatment goals and expectations, is essential before initiating a GLP-1 plan to ensure appropriateness and safety
With appropriate clinical trials, this gastric pentadecapeptide may ultimately provide clinically valuable applications for conditions currently lacking optimal treatment options
Some of the most common or potential side effects include: Nausea Constipation Vomiting Diarrhea Abdominal Pain Headache Indigestion Injection site reactions Dizziness Back pain Increased Lipase or Amylase Altered taste Nasopharyngitis (common cold) Passing Gas Bloating Belching Gastroenteritis Decreased appetite Fatigue Gastroesophageal reflux disease Low blood sugar (hypoglycemia) in those with Type 2 diabetes Upset stomach These symptoms often subside as your body adjusts to the medications
Your first vial lasts through both of these phases with plenty to spare
These changes mean you eat less food and absorb fewer calories and nutrients, and it changes the hormones that influence your appetite and satiety
Comprising the active ingredient semaglutide , its become a talked about medication due to its effectiveness and FDA-approved status for diabetes control